612 related articles for article (PubMed ID: 32212001)
1. The spectrum of idiopathic inflammatory myopathies in South Africa.
Chinniah KJ; Mody GM
Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
[TBL] [Abstract][Full Text] [Related]
2. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
[TBL] [Abstract][Full Text] [Related]
3. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
[TBL] [Abstract][Full Text] [Related]
4. Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry.
Nuño-Nuño L; Joven BE; Carreira PE; Maldonado-Romero V; Larena-Grijalba C; Llorente Cubas I; Tomero E; Barbadillo-Mateos MC; García de la Peña Lefebvre P; Ruiz-Gutiérrez L; López-Robledillo JC; Moruno-Cruz H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; García de Yébenes MJ; López-Longo FJ
Int J Rheum Dis; 2019 Aug; 22(8):1393-1401. PubMed ID: 30968571
[TBL] [Abstract][Full Text] [Related]
5. Nailfold capillaroscopy changes with disease activity in patients with inflammatory myositis including overlap myositis, pure dermatomyositis, and pure polymyositis.
Shenavandeh S; Rashidi F
Reumatologia; 2022; 60(1):42-52. PubMed ID: 35645422
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
7. Cancer Risk and Mortality in Hospitalized Patients With Idiopathic Inflammatory Myopathies in Western Australia.
Nossent JC; Keen H; Preen D; Inderjeeth C
J Rheumatol; 2024 Apr; 51(4):396-402. PubMed ID: 38302176
[TBL] [Abstract][Full Text] [Related]
8. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
9. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
[TBL] [Abstract][Full Text] [Related]
10. First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.
Jinnin M; Ohta A; Ishihara S; Amano H; Atsumi T; Fujimoto M; Kanda T; Kawaguchi Y; Kawakami A; Mimori A; Mimori T; Mimura T; Muro Y; Sano H; Shimizu J; Takeuchi T; Tanaka Y; Yamamoto K; Sumida T; Kohsaka H;
Ann Rheum Dis; 2020 Mar; 79(3):387-392. PubMed ID: 31694813
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic inflammatory myopathies: a review.
Ashton C; Paramalingam S; Stevenson B; Brusch A; Needham M
Intern Med J; 2021 Jun; 51(6):845-852. PubMed ID: 34155760
[TBL] [Abstract][Full Text] [Related]
12. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.
Dobloug GC; Garen T; Brunborg C; Gran JT; Molberg Ø
Semin Arthritis Rheum; 2015 Dec; 45(3):301-8. PubMed ID: 26190563
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of idiopathic inflammatory myopathies in Western Australia: epidemiological characteristics and mortality over time.
Nossent J; Keen H; Preen DB; Inderjeeth CA
Rheumatol Int; 2024 Feb; 44(2):329-337. PubMed ID: 37819456
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival of patients with idiopathic inflammatory myopathies: anatomy of a single-centre cohort.
Guimarães F; Yildirim R; Isenberg DA
Clin Exp Rheumatol; 2023 Mar; 41(2):322-329. PubMed ID: 36861745
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study.
Cho SK; Kim H; Myung J; Nam E; Jung SY; Jang EJ; Yoo DH; Sung YK
J Korean Med Sci; 2019 Mar; 34(8):e55. PubMed ID: 30833879
[TBL] [Abstract][Full Text] [Related]
16. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
17. The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.
Parker MJS; Oldroyd A; Roberts ME; Lilleker JB; Betteridge ZE; McHugh NJ; Herrick AL; Cooper RG; Chinoy H
Rheumatology (Oxford); 2019 Mar; 58(3):468-475. PubMed ID: 30496561
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort.
Naveen R; Rathore U; Agarwal V; Gupta L
Rheumatol Int; 2021 Mar; 41(3):551-563. PubMed ID: 33423071
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
[TBL] [Abstract][Full Text] [Related]
20. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
